Le Lézard
Classified in: Health
Subjects: VET, MAT, DEI

Delta 8 THC is Helping Veterans in Many Ways


INDIANAPOLIS, Nov. 11, 2021 /PRNewswire/ -- For veterans with PTSD, chronic pain, anxiety, and more, life can seem overwhelming sometimes. One thing that has helped many veterans cope with their symptoms is medical cannabis. But the Department of Veteran Affairs (VA) hasn't made things easy for veterans to get the help they need. This has led many to choose a safe and legal alternative called Delta 8.

Veterans appreciate the use of Delta 8 for its potential advantages, affordability and legality.

Delta 8 is a federally legal cannabinoid which offers similar effects to medical cannabis without some of the unwanted side effects of cannabis, which contains Delta 9. Delta 9 is known to be more intoxicating than Delta 8, and it can cause an increase in paranoia and anxiety, along with confusion and a clouded head for some. Consumers, including veterans, have said Delta 8 doesn't have the unwanted side effects while also helping them with their anxiety, PTSD, and chronic pain. 

Additionally, several veterans have reported they have an improved quality of life. They are experiencing less pain. Plus, those who take Delta 8 also say they have been able to reduce the amount of opioids they take with the help and guidance of their doctor. Recent studies have shown the same benefits of cannabis. Consumers are using more cannabis and medical cannabis over opioids, leading to less addiction and dependence on opioids during a countrywide epidemic.

Even though the VA says they are still looking into the potential benefit of cannabis for military veterans with PTSD, federal lawmakers are moving things forward. Most recently, House and Senate subcommittees both approved research efforts requiring the VA to take action. A key will be research on medical cannabis for PTSD veterans as a potential alternative to opioids.

In the meantime, veterans appreciate the use of Delta 8 for its potential advantages, affordability and legality. 

3Chi is a pioneer in science-based cannabis research and was the first commercial developer of hemp-derived Delta-8 THC. Based in Indiana, the company continues today as an industry leader in emerging cannabis science and innovative hemp-derived products. To learn more, click here: 3Chi.com

For questions and media inquiries, please reach out to: [email protected]

SOURCE 3Chi


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: